ADVANCEMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL APPS

Recombinant human serum albumin (OsrHSA) has emerged as a major innovation in the field of biopharmaceuticals, providing promising developments throughout a variety of clinical and industrial purposes. With its structural similarity to The natural way derived human serum albumin, OsrHSA provides a safer, far more trustworthy choice for therapeutic